Insmed | INSM - Employees Total Number

Stock Price
146.44
Daily Change
1.34 0.92%
Monthly
29.72%
Yearly
103.90%
Q3 Forecast
143.90

Insmed reported 1.27K in Employees for its fiscal year ending in December of 2024.



Financials
Stock Price USD
Assets USD 2.48B
Cash and Equivalent USD 1.28B
Cost of Sales USD 29.34M
Current Assets USD 2.08B
Current Liabilities USD 311.68M
Debt USD 564.1M
EBIT USD -253.88M
EBITDA USD -297.13M
Employees 1.27K
EPS Earnings Per Share USD -1.7
Equity Capital and Reserves USD 1.25B
Gross Profit on Sales USD 78.08M
Interest Expense on Debt USD 21.25M
Interest Income 0
Loan Capital USD 560.95M
Market Capitalization USD 21.64B
Net Income USD -321.69M
Operating Expenses USD 361.29M
Operating Profit USD -253.88M
Ordinary Share Capital USD 211.11M
Pre-Tax Profit USD -320.44M
Sales Revenues USD 107.4M
Selling and Administration Expenses USD 76.44M
Stock USD 107.61M
Trade Creditors USD 78.35M
Trade Debtors USD 55.03M

Employees Change Date
BioMarin Pharmaceutical 3.04K 361 Dec/2024
Cytokinetics 498 75 Dec/2024
DBV Technologies 104 19 Dec/2023
Dynavax Technologies 405 3 Dec/2024
Gilead Sciences 17.6K 400 Dec/2024
Insmed 1.27K 359 Dec/2024
Novartis 101.7K 2.62K Dec/2022
Sarepta Therapeutics 1.37K 58 Dec/2024
Ultragenyx Pharmaceutical 1.29K 18 Dec/2024
Vertex Pharmaceuticals 6.1K 700 Dec/2024